Alternate day fasting for weight loss in normal weight and overweight subjects: a randomized controlled trial

Nutrition Journal

Table 3 Lipid coronary heart disease risk factor changes during the 12-week study

	Intervention	Week 1¹	Week 12	P-value²	P-value³	Change⁴	P-value⁵
Total cholesterol (mg/dl)	ADF	201 ± 9	175 ± 12	<0.01	0.12	-26 ± 6	0.50
	Control	211 ± 11	202 ± 9	0.54		-9 ± 5
LDL cholesterol (mg/dl)	ADF	118 ± 9	99 ± 9	0.01	0.82	-18 ± 6	0.29
	Control	128 ± 10	119 ± 6	0.08		-9 ± 4
HDL cholesterol (mg/dl)	ADF	56 ± 3	54 ± 4	0.49	0.77	-2 ± 3	0.51
	Control	57 ± 2	58 ± 4	0.83		1 ± 2
Triacylglycols (mg/dl)	ADF	109 ± 13	87 ± 9	0.06	0.01	-22 ± 11	0.22
	Control	108 ± 18	118 ± 19	0.34		10 ± 7
Non-HDL cholesterol (mg/dl)	ADF	149 ± 11	124 ± 12	<0.01	0.54	-25 ± 5	0.96
	Control	153 ± 12	144 ± 10	0.79		-9 ± 5
LDL particle size (Å)	ADF	254 ± 1	258 ± 2	<0.01	<0.01	4 ± 1	0.13
	Control	252 ± 2	250 ± 3	0.16		-2 ± 1

Values reported as mean ± SEM. ADF: Alternate day fasting.
¹Baseline values were not significantly different between intervention groups for any parameter: Independent samples t-test.
²P-value between week 1 and week 12: Paired t-test.
³P-value between groups at week 12: Independent samples t-test.
⁴Absolute change between week 1 and week 12 values.
⁵P-value between groups for absolute change: Independent samples t-test.

ISSN: 1475-2891